Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 The clinical information of 25 PTL patients

From: Genomic landscape and distinct molecular subtypes of primary testicular lymphoma

 

Total

Age

 Mean (SD)

63.7 (± 12.1)

Diagnose

 DLBCL

25 (100%)

Pathology

 nonGCB

22 (88.0%)

 GCB

3 (12.0%)

Stage

 I

3 (12.0%)

 II

7 (28.0%)

 III

2 (8.0%)

 IV

13 (52.0%)

B symptom

 Yes

5 (20.0%)

 No

20 (80.0%)

ECOG

 0

20 (80.0%)

 1

3 (12.0%)

 2

1 (4.0%)

 4

1 (4.0%)

IPI

 0

2 (8.0%)

 1

1 (4.0%)

 2

12 (48.0%)

 3

6 (24.0%)

 4

3 (12.0%)

 5

1 (4.0%)

Recurrence

 Yes

9 (36.0%)

 No

16 (64.0%)